Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
Clinical trial NCT00482846 · COMPLETED
Trial details
- NCT number
- NCT00482846
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.